The antihyperlipidaemic FM-VP4 reduces arterial plaque development

By  

Inpharma, Vol. 1, Iss. 1243, 2000-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Pre-treatment with a DPP-4 Inhibitor is Infarct Sparing in Hearts from Obese, Pre-diabetic Rats

By Huisamen Barbara   Genis Amanda   Marais Erna   Lochner Amanda  

Cardiovascular Drugs and Therapy, Vol. 25, Iss. 1, 2011-02 ,pp. : 13-20

Springer Publishing Company

Access to resources Recommend Favorite

Co-agonist of glucagon and GLP-1 reduces cholesterol and improves insulin sensitivity independent of its effect on appetite and body weight in diet-induced obese C57 mice

By Joharapurkar Amit   Dhanesha Nirav   Kshirsagar Samadhan   Patel Kartik   Bahekar Rajesh   Shah Gaurang   Jain Mukul  

Canadian Journal of Physiology and Pharmacology, Vol. 91, Iss. 12, 2013-01 ,pp. : 1009-1015

NRC Research Press

Access to resources Recommend Favorite

Cholesterol Absorption Inhibitors for the Treatment of Hypercholesterolaemia

By Sudhop T.   von Bergmann K.  

Drugs, Vol. 62, Iss. 16, 2002-01 ,pp. : 2333-2347

Adis International

Access to resources Recommend Favorite

The Effect of Chlorogenic Acid Enriched Coffee on Glucose Absorption in Healthy Volunteers and Its Effect on Body Mass When Used Long-term in Overweight and Obese People

By Thom E  

The Journal of International Medical Research, Vol. 35, Iss. 6, 2007-11 ,pp. : 900-908

Field House Publishing

Access to resources Recommend Favorite